Dendritic cells (DCs) are professional antigen-presenting cells and have critical roles in regulating immune responses. Prostaglandin I2 (PGI2) analogs are considered to be potential treatments for asthma. However, the effect of PGI2 analogs on human monocyte-derived DCs (MDDCs) is still not clearly understood.
Methods
Human MDDCs were pretreated with iloprost and treprostinil (2 PGI2 analogs) or forskolin (an adenyl cyclase activator) before lipopolysaccharide (LPS) stimulation. In some cases, I prostanoid (IP) receptor and E prostanoid receptor antagonists were added before the PGI2 analog treatment. tumor necrosis factor α (TNF-α) was measured by enzyme-linked immunosorbent assay. The expression of costimulatory molecules was assessed by flow cytometry. T-cell polarization function was investigated by measuring interferon γ, interleukin 13 (IL-13), and IL-17A production by T cells cocultured with iloprost-treated MDDCs.
Results
Iloprost and treprostinil suppressed LPS-induced TNF-α expression in MDDCs. This effect could be reversed by an IP receptor antagonist, CAY10449, but not by E prostanoid receptor antagonists. Forskolin conferred a similar effect. Iloprost suppressed the LPS-induced expression of costimulatory molecules, including CD80, CD86, CD40, and HLA-DR. Iloprost-treated MDDCs increased IL-17A production by T cells.
Conclusions
Prostaglandin I2 analogs may exert anti-inflammatory effects by suppressing TNF-α expression via the IP receptor-cyclic adenosine monophosphate pathways and by inhibiting the expression of costimulatory molecules in human MDDCs.
BrightlingC, BerryM, AmraniY.Targeting TNF-alpha: a novel therapeutic approach for asthma. J Allergy Clin Immunol. 2008;121:5–10; >quiz 11–12>.
4.
BerryMA, HargadonB, ShelleyM, . Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006;354:697–708.
5.
KrutzikSR, TanB, LiH, . TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat Med. 2005;11:653–660.
6.
LambrechtBN, HammadH.Biology of lung dendritic cells at the origin of asthma. Immunity. 2009;31:412–424.
7.
HsuSC, ChenCH, TsaiSH, . Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN), on human dendritic cells. J Biol Chem. 2010;285:7903–7910.
8.
CharbonnierAS, HammadH, GossetP, . Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J Leukoc Biol. 2003;73:91–99.
9.
AronoffDM, PeresCM, SerezaniCH, . Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities. J Immunol. 2007;178:1628–1634.
10.
IdzkoM, HammadH, van NimwegenM, . Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest. 2007;117:464–472.
11.
HungCH, ChuYT, SuenJL, . Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues. Eur Respir J. 2009;33:405–410.
12.
KuoCH, JanRL, ChuYT, . Prostaglandin I2 analogues enhance growth-related oncogene-α expression in human monocyte-derived dendritic cells. Inflammation. 2010;33:334–343.
13.
ZhouW, HashimotoK, GoleniewskaK, . Prostaglandin I2 analogs inhibit proinflammatory cytokine production and T cell stimulatory function of dendritic cells. J Immunol. 2007;178:702–710.
MubarakKK.A review of prostaglandin analogs in the management of patients with pulmonary arterial hypertension. Respir Med. 2010;104:9–21.
16.
KapsenbergML.Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003;3:984–993.
17.
VincentiF.Costimulation blockade in autoimmunity and transplantation. J Allergy Clin Immunol. 2008;121:299–306; >quiz 307–308>.
18.
ShortmanK, LiuYJ.Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–161.
19.
BellinghausenI, BrandU, KnopJ, . Comparison of allergen-stimulated dendritic cells from atopic and nonatopic donors dissecting their effect on autologous naive and memory T helper cells of such donors. J Allergy Clin Immunol. 2000;105:988–996.
20.
SaekiS, MatsuseH, KondoY, . Effects of antiasthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients. J Allergy Clin Immunol. 2004;114:538–544.
21.
MichelO, KipsJ, DuchateauJ, . Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med. 1996;154:1641–1646.
22.
ThornePS, KulhankovaK, YinM, . Endotoxin exposure is a risk factor for asthma: the national survey of endotoxin in United States housing. Am J Respir Crit Care Med. 2005;172:1371–1377.
23.
EisenbarthSC, PiggottDA, HuleattJW, . Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med. 2002;196:1645–1651.
24.
WilsonRH, WhiteheadGS, NakanoH, . Allergic sensitization through the airway primes TH17-dependent neutrophilia and airway hyperresponsiveness. Am J Respir Crit Care Med. 2009;180:720–730.
NagaoK, TanakaH, KomaiM, . Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol. 2003;29:314–320.
27.
WhartonJ, DavieN, UptonPD, . Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation. 2000;102:3130–3136.
28.
CrutchleyDJ, SolomonDE, ConananLB.Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism. Arterioscler Thromb. 1992;12:664–670.
29.
KuoCH, KoYC, YangSN, . Effects of PGI(2) analogues on TH1- and TH2-related chemokines in monocytes via epigenetic regulation. J Mol Med. 2011;89:29–41.
30.
SallustoF, CellaM, DanieliC, . Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389–400.
31.
HuhJC, StricklandDH, JahnsenFL, . Bidirectional interactions between antigen-bearing respiratory tract dendritic cells (DCs) and T cells precede the late phase reaction in experimental asthma: DC activation occurs in the airway mucosa but not in the lung parenchyma. J Exp Med. 2003;198:19–30.
32.
PoulsenLK, HummelshojL.Triggers of IgE class switching and allergy development. Ann Med. 2007;39:440–456.
33.
SuzukiM, ZhengX, ZhangX, . Inhibition of allergic responses by CD40 gene silencing. Allergy. 2009;64:387–397.
34.
van RijtLS, VosN, WillartM, . Essential role of dendritic cell CD80/CD86 costimulation in the induction, but not reactivation, of TH2 effector responses in a mouse model of asthma. J Allergy Clin Immunol. 2004;114:166–173.
35.
AgeaE, ForenzaN, PiattoniS, . Expression of B7 co-stimulatory molecules and CD1a antigen by alveolar macrophages in allergic bronchial asthma. Clin Exp Allergy. 1998;28:1359–1367.
36.
BurasteroSE, MagnaniZ, ConfettiC, . Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J Allergy Clin Immunol. 1999;103:1136–1142.
37.
OnishiRM, GaffenSL.Interleukin -17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129:311–321.
38.
Schnyder-CandrianS, TogbeD, CouillinI, . Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203:2715–2725.
39.
AgacheI, CiobanuC, AgacheC, . Increased serum IL-17 is an independent risk factor for severe asthma. Respir Med. 2010;104:1131–1137.
40.
JaffarZ, FerriniME, BufordMC, . Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ TH2 cells into the airways in a mouse model of asthma. J Immunol. 2007;179:6193–6203.
41.
CzeslickEG, SimmA, GrondS, . Inhibition of intracellular tumour necrosis factor (TNF)-alpha and interleukin (IL)-6 production in human monocytes by iloprost. Eur J Clin Invest. 2003;33:1013–1017.
42.
MullerT, DurkT, BlumenthalB, . Iloprost has potent anti-inflammatory properties on human monocyte-derived dendritic cells. Clin Exp Allergy. 2010;40:1214–1221.
